(Q49155216)

18 February 2018

title

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies. (English)

1 reference

18 February 2018

1 reference

1 reference

4

Michael Schotsaert

1 reference

18 February 2018

Xavier Saelens

8

object named as

Xavier Saelens

1 reference

18 February 2018

Walter Fiers

7

object named as

Walter Fiers

1 reference

18 February 2018

author name string

Marina De Filette

1

1 reference

18 February 2018

Wouter Martens

2

1 reference

18 February 2018

Anouk Smet

3

1 reference

18 February 2018

Ashley Birkett

5

1 reference

18 February 2018

Patricia Londoño-Arcila

6

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 December 2008

1 reference

18 February 2018

published in

Vaccine

1 reference

18 February 2018

volume

26

1 reference

18 February 2018

issue

51

1 reference

18 February 2018

page(s)

6503-6507

1 reference

18 February 2018

Making better influenza virus vaccines?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Prospects for universal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Universal influenza A vaccine: optimization of M2-based constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Behavioral thermoregulation in mice inoculated with influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Clinical course and consequences of hepatitis B infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Immune tolerance split between hepatitis B virus precore and core proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Antibody response to the M2 protein of influenza A virus expressed in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.09.038

1 reference

18 February 2018

PubMed ID

18835315

1 reference

18 February 2018